Asian Phytoceuticals Public Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 09, 2022 at 06:48 am
Share
Asian Phytoceuticals Public Company Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was THB 62.78 million compared to THB 54.99 million a year ago. Net income was THB 20.92 million compared to THB 18.96 million a year ago. Basic earnings per share from continuing operations was THB 0.0349 compared to THB 0.0316 a year ago.
For the nine months, sales was THB 176.18 million compared to THB 161.25 million a year ago. Net income was THB 53.42 million compared to THB 47.17 million a year ago. Basic earnings per share from continuing operations was THB 0.089 compared to THB 0.0786 a year ago.
Asian Phytoceuticals Public Company Limited is a Thailand-based company, which is engaged in business of research and development, manufacturing, and distribution of its products for health and natural beauty. It operates through the manufacturing and distribution of dietary supplements from herbs. The Companyâs products and brands include operation balancing immunity (BIM), longevity, and slimming and beauty products. Its operation BIM includes Mylife, LIV Capsule, Garcinia, Arthrinox, Diabenok, Tumorid capsule, Noriasis, Canvirol and others. The Companyâs slimming products include Asian Life Revitalizing Serum, Asian Life Revitalizing Cream, Garcinia Acne Cream, Garcinia Facial Cleansing Gel, Garcinia Cleansing Cream, Noriasis Nourishing Skin Cream, and others. The Company, through its subsidiary, Killer T Cell for Pets Co., Ltd., is engaged in the business of distribution and marketing of pharmaceutical food supplements in the global animal market.
ASIAN PHYTOCEUTICALS 